Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Idenix Pharmaceuticals Inc    NO9   US45166R2040

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Idenix Pharmaceuticals Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales10,26,9569,73,509,3320,2
Operating income (EBITDA)--49,2-32,3-124-121-146
Operating profit (EBIT)-62,7-53,4-35,4-119-110-88,7
Pre-Tax Profit (EBT)---32,5---
Net income-61,6-52,0-32,4-118-99,3-75,4
EPS ( $)-0,87-0,57-0,27-0,91-0,81-0,61
Dividend per Share ( $)------
Yield------
Announcement Date02/28/2011
09:05pm
02/23/2012
09:05pm
02/25/2013
09:05pm
---
Finances - Leverage
Idenix Pharmaceuticals Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance-11823113712715,6
Operating income (EBITDA)--49,2-32,3-124-121-146
Leverage
(Debt/EBITDA)
------
Capital Expenditure-0,841,074,600,350,30
Book Value Per Share (BVPS)-0,48 $1,64 $0,93 $1,01 $0,10 $
Cash Flow per Share-0,40 $-0,60 $-0,69 $-0,74 $-0,70 $-1,41 $
Announcement Date02/28/2011
09:05pm
02/23/2012
09:05pm
02/25/2013
09:05pm
---
Balance Sheet Analysis
Idenix Pharmaceuticals Inc : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 577 M$ -
Company Value 440 M$ 451 M$
Valuation 2013e 2014e
PER (Price / EPS)
Capitalization / Revenue 165x 61,9x
EV / Revenue 126x 48,3x
EV / EBITDA -3,56x -3,73x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) -3 397% -1 179%
operating laverage (Delta EBIT / Delta Sales) -2,49x 0,05x
Net Margin (Net Profit / Revenue) -3 377% -1 065%
ROA (Net Profit / Asset) -36,0% -1,00%
ROE (Net Profit / Equities) -65,4% -98,0%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   131% 3,78%
Cash Flow / Sales (Taux d'autofinancement) -2 813% -1 006%
Capital Intensity (Assets / Sales) 93,8x 1 065x
Financial Leverage (Net Debt / EBITDA) 1,11x 1,05x
EPS & Dividend
Idenix Pharmaceuticals Inc : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.